FDA issued a Warning Letter to Pharmakon Pharmaceuticals on 5/21/2015 for a later inspection.
483 Pharmakon Pharmaceuticals Apr 2014

483 Pharmakon Pharmaceuticals Apr 2014

Meisha Waters FDA, Meisha Sampson FDA$119.00 - Available Now

FDA investigators audited the Pharmakon Pharmaceuticals - Noblesville, IN, United States facility and issued 4 inspectional observations (via FDA 483) on 08 Apr 2014.

Product details

  • Category: Human Drugs
  • Number of Observations: 4
  • Inspection end: 08 Apr 2014
  • Location: Noblesville, United States
  • FEI: 3008213711
Add To Cart